Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection
Clinical trial NCT04366830 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04366830
- Sponsor
- Mesoblast International Sàrl
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.